Article
Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes.
Gut - 1 Jul 2009
Mengshol J A, Golden-Mason L, Castelblanco N, Im K A, Dillon S M, Wilson C C, Rosen H R
Abstract excerpt
BACKGROUND: Dendritic cell (DC) defects may contribute to chronicity in hepatitis C virus (HCV) infection and determine response to PEG-interferon and ribavirin therapy via poor T cell stimulation. Studies to date have produced inconsistent results regarding DC maturation and function: no large study has examined DCs before and after therapy. AIMS: We examined if DC defects in maturation and chemotaxis are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
